Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Antimicrobial resistance (AMR) is a high priority across countries as it increases morbidity, mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally, nationally and regionally to enhance appropriate antibiotic utilization across sectors to reduce AMR, with the overuse of antibiotics exacerbated by the COVID-19 pandemic. Effectively tackling AMR is crucial for all countries. Principally a narrative review of ongoing activities across sectors was undertaken to improve antimicrobial use and address issues with vaccines including COVID-19. Point prevalence surveys have been successful in hospitals to identify areas for quality improvement programs, principally centering on antimicrobial stewardship programs. These include reducing prolonged antibiotic use to prevent surgical site infections. Multiple activities centering on education have been successful in reducing inappropriate prescribing and dispensing of antimicrobials in ambulatory care for essentially viral infections such as acute respiratory infections. It is imperative to develop new quality indicators for ambulatory care given current concerns, and instigate programs with clear public health messaging to reduce misinformation, essential for pandemics. Regular access to effective treatments is needed to reduce resistance to treatments for HIV, malaria and tuberculosis. Key stakeholder groups can instigate multiple initiatives to reduce AMR. These need to be followed up.
Top-30
Journals
|
5
10
15
20
25
30
35
|
|
|
Antibiotics
34 publications, 20.24%
|
|
|
JAC-Antimicrobial Resistance
21 publications, 12.5%
|
|
|
Expert Review of Anti-Infective Therapy
7 publications, 4.17%
|
|
|
Medicina
6 publications, 3.57%
|
|
|
Infection and Drug Resistance
5 publications, 2.98%
|
|
|
Frontiers in Tropical Diseases
5 publications, 2.98%
|
|
|
Hospital practice (1995)
4 publications, 2.38%
|
|
|
Cureus
4 publications, 2.38%
|
|
|
Frontiers in Public Health
3 publications, 1.79%
|
|
|
Frontiers in Pharmacology
3 publications, 1.79%
|
|
|
Advances in Human Biology
3 publications, 1.79%
|
|
|
Healthcare
2 publications, 1.19%
|
|
|
Antimicrobial Resistance and Infection Control
2 publications, 1.19%
|
|
|
Pharmacology & Pharmacy
2 publications, 1.19%
|
|
|
Journal of Multidisciplinary Healthcare
2 publications, 1.19%
|
|
|
Microorganisms
2 publications, 1.19%
|
|
|
Journal of Pharmaceutical Policy and Practice
2 publications, 1.19%
|
|
|
Frontiers in Pediatrics
2 publications, 1.19%
|
|
|
Wellcome Open Research
2 publications, 1.19%
|
|
|
Scientific Reports
2 publications, 1.19%
|
|
|
Frontiers in Microbiology
2 publications, 1.19%
|
|
|
BMC Infectious Diseases
2 publications, 1.19%
|
|
|
Discover Public Health
2 publications, 1.19%
|
|
|
Pharmacoepidemiology
1 publication, 0.6%
|
|
|
Gates Open Research
1 publication, 0.6%
|
|
|
Hospital Pharmacy
1 publication, 0.6%
|
|
|
Energies
1 publication, 0.6%
|
|
|
Tropical Medicine and Infectious Disease
1 publication, 0.6%
|
|
|
Vaccines
1 publication, 0.6%
|
|
|
5
10
15
20
25
30
35
|
Publishers
|
5
10
15
20
25
30
35
40
45
50
|
|
|
MDPI
48 publications, 28.57%
|
|
|
Taylor & Francis
24 publications, 14.29%
|
|
|
Oxford University Press
22 publications, 13.1%
|
|
|
Springer Nature
21 publications, 12.5%
|
|
|
Frontiers Media S.A.
16 publications, 9.52%
|
|
|
Elsevier
8 publications, 4.76%
|
|
|
Wiley
4 publications, 2.38%
|
|
|
F1000 Research
3 publications, 1.79%
|
|
|
SAGE
2 publications, 1.19%
|
|
|
Scientific Research Publishing
2 publications, 1.19%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.19%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.19%
|
|
|
Medknow
2 publications, 1.19%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.6%
|
|
|
American Chemical Society (ACS)
1 publication, 0.6%
|
|
|
Cambridge University Press
1 publication, 0.6%
|
|
|
Volgograd State Medical University
1 publication, 0.6%
|
|
|
Veterinary World
1 publication, 0.6%
|
|
|
Baishideng Publishing Group
1 publication, 0.6%
|
|
|
Research Square Platform LLC
1 publication, 0.6%
|
|
|
BMJ
1 publication, 0.6%
|
|
|
Jaypee Brothers Medical Publishing
1 publication, 0.6%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.6%
|
|
|
5
10
15
20
25
30
35
40
45
50
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.